Association between immune-related adverse events and immunotherapy efficacy in non-small-cell lung cancer: a meta-analysis
Objective: Our study aimed to identify potential correlations between anti-tumor efficacy and immune-related adverse events (irAEs) in non-small-cell lung cancer (NSCLC).Methods: We conducted a comprehensive search of online electronic databases up to March 2023 to identify any correlations between...
Main Authors: | Li Lin, Yu Liu, Chen Chen, Anhua Wei, Wei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1190001/full |
Similar Items
-
Rheumatological Adverse Events Following Immunotherapy for Cancer
by: Ioana Cretu, et al.
Published: (2022-01-01) -
Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors
by: You-Cheng Zhang, et al.
Published: (2023-01-01) -
Correlation Analysis between Thyroid Function Abnormality and Efficacy in Patients
with Advanced Non-small Cell Lung Cancer after Immunotherapy
by: Yibo WANG, et al.
Published: (2023-05-01) -
The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer
by: Courtney H. Coschi, et al.
Published: (2021-11-01) -
Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor
by: Kazuyuki Hamada, et al.
Published: (2023-05-01)